FDA Adverse Event Injury Summary report: N

ALAIR BRONCHIAL THERMOPLASTY CATHETER

MDR report key: 2972799 · Received February 21, 2013

Report

Report Number
3005099803-2013-01115
Event Type
Injury
Date Received
February 21, 2013
Date of Event
December 29, 2010
Report Date
January 28, 2013
Manufacturer
BOSTON SCIENTIFIC - SAN JOSE
Product Code
OOY
PMA / PMN Number
P080032
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE PATIENT'S BMI WAS REPORTED TO BE 24.5. (B)(4). LITERATURE SOURCE: DOEING, DIANA C., MAHAJAN, AMIT K., WHITE, STEVEN R., NAURECKAS, EDWARD T., KRISHNAN, JERRY A. AND DOUGLAS K. HOGARTH. "SAFETY AND FEASIBILITY OF BRONCHIAL THERMOPLASTY IN ASTHMA PATIENTS WITH VERY SEVERE FIXED AIRFLOW OBSTRUCTION: A CASE SERIES." JOURNAL OF ASTHMA (2012): 1-4. WEB. THE COMPLAINANT INDICATED THAT THE DEVICE WAS DISPOSED AND WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CORPORATION BECAME AWARE OF AN EVENT DETAILED WITHIN THE LITERATURE ARTICLE "SAFETY AND FEASIBILITY OF BRONCHIAL THERMOPLASTY IN ASTHMA PATIENTS WITH VERY SEVERE FIXED AIRFLOW OBSTRUCTION: A CASE SERIES", IN WHICH AN ALAIR CATHETER WAS USED DURING A BRONCHIAL THERMOPLASTY PROCEDURE. THIS COMPLAINT IS BEING REPORTED BASED ON THE EVENT OF LOWER RESPIRATORY TRACT INFECTION TREATED WITH ANTIBIOTICS. ACCORDING TO THE COMPLAINANT, THE PATIENT UNDERWENT HIS THIRD BRONCHIAL THERMOPLASTY (BT) PROCEDURE, ON (B)(6) 2010, THE PATIENT DEVELOPED MILD HEMOPTYSIS. A BRONCHOSCOPIC INSPECTION FOLLOWING THE HEMOPTYSIS DID NOT REVEAL A SOURCE OF THE BLEEDING AND THE PATIENT DID NOT REQUIRE FURTHER INTERVENTION. ON (B)(6), 2010, THE PATIENT WAS DIAGNOSED WITH A LOWER RESPIRATORY TRACT INFECTION. THE INFECTION WAS TREATED WITH AZITHROMYCIN AND MOXIFLOXACIN. THE INFECTION HAS RESOLVED. AS PER THE PROTOCOL, THE PATIENT RECEIVED PREDNISONE (50MG DAILY) FOR THREE DAYS, PRIOR TO THE DAY OF THE PROCEDURE, AT THE DAY OF THE PROCEDURE, AND ONE DAY AFTER THE BT PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
76569 ALAIR BRONCHIAL THERMOPLASTY CATHETER ELECTROSURGICAL, BRONCHIAL THERMOPLASTY CATHETER & SYSTEM & ACCESSORIES OOY BOSTON SCIENTIFIC - SAN JOSE M005ATS25010

Patients

Seq Age Sex Outcome Treatment
1 58 YR Required Intervention